Loading... 2 0 20 0 false
 
Name
Cano, Amanda
 
 
 
Biography
Amanda Cano holds a postdoctoral researcher position in the clinical research department of Ace Alzheimer Center Barcelona. Previously, she was an adjunct professor of Physical Chemistry at the University of Barcelona. She graduated from Pharmacy at the University of Salamanca in 2013 and received her master’s degree in 2014 from the University of Barcelona. In 2018, she finished her Ph.D. studies on nanomedicine and neuropharmacology, and obtained the doctoral degree from the University of Barcelona. In this period, she also combined experimental activity with teaching experience. She carried out several international research stays at the University of Trás-os-Montes and Alto Douro in Portugal, the University College of London in the United Kingdom, and the University of Modena and Reggio Emilia in Italy. She is a member of the Consolidated Research Group of the Generalitat de Catalunya “Nanostructured systems for the controlled release of drugs” (2017SGR-1477), Institute of Nanoscience and Nanotechnology (IN2UB), and Center for Biomedical Research in Neurodegenerative Diseases Network (CIBERNED). She has obtained several competitive fellowships to develop her scientific career, and possess the official credentials of Assistant Professor of the National Agency for Evaluation and Accreditation (ANECA) of the Ministry of Science (Spanish government) and of the Agency for the Quality of the University System of Catalonia (AQU) (Generalitat of Catalunya). She has participated in several competitive European projects, competitive national projects, and non-competitive national and international projects. In 2020, she started her postdoctoral studies related to clinical evaluation of early biomarkers of Alzheimer’s disease. Likewise, she participates as a pharmacist in clinical trials at the Ace Alzheimer Center Barcelona, having participated in multiple clinical trials on Alzheimer’s disease to date.
Loading... 3 0 20 0 false

Publications
(All)

Results 1-12 of 12 (Search time: 0.015 seconds).

Issue DateTitleAuthor(s)TypeAccess
1Aug-2022Biodegradable nanoparticles for the treatment of epilepsy: From current advances to future challengesBonilla, Lorena; Esteruelas, Gerard; Ettcheto, Miren; Espina, Marta; García, María Luisa; Camins, Antoni; Souto, Eliana B. ; Cano, Amanda ; Sánchez-López, ElenaarticleopenAccess
29-Sep-2021Elastic and Ultradeformable Liposomes for Transdermal Delivery of Active Pharmaceutical Ingredients (APIs)Souto, Eliana ; Macedo, Ana S; Dias-Ferreira, João ; Cano, Amanda ; Zielińska, Aleksandra ; Matos, Carla M.articleopenAccess
318-Oct-2021Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular PathwaysCano, Amanda ; Fonseca, Elena; Ettcheto, Miren; Sánchez-López, Elena; de Rojas, Itziar; Alonso-Lana, Silvia; Morató, Xavier; Souto, Eliana B. ; Toledo, Manuel; Boada, Mercè ; Marquié, Marta; Ruíz, AgustínarticleopenAccess
416-Sep-2023Licochalcone A: A Potential Multitarget Drug for Alzheimer's Disease TreatmentOlloquequi, Jordi; Ettcheto, Miren; Cano, Amanda ; Fortuna, A. ; Bicker, Joana ; Sánchez-López, Elena ; Paz, Cristian; Ureña, Jesús; Verdaguer, Ester; Auladell, Carme; Camins, AntoniarticleopenAccess
54-Aug-2021Lipid-Polymeric Films: Composition, Production and Applications in Wound Healing and Skin RepairSouto, Eliana B. ; Yoshida, Cristiana M. P.; Leonardi, Gislaine R.; Cano, Amanda ; Sanchez-Lopez, Elena; Zielińska, Aleksandra ; Viseras, César; Severino, Patrícia ; Silva, Classius F. da; Barbosa, Raquel de M.articleopenAccess
627-Mar-2018Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterizationSánchez-López, Elena ; Ettcheto, Miren; Egea, Maria Antonia; Espina, Marta; Cano, Amanda ; Calpena, Ana Cristina; Camins, Antoni; Carmona, Nuria; Silva, Amelia M.; Souto, Eliana B. ; García, Maria LuisaarticleopenAccess
79-Feb-2020Metal-Based Nanoparticles as Antimicrobial Agents: An OverviewSánchez-López, Elena; Gomes, Daniela ; Esteruelas, Gerard; Bonilla, Lorena; Lopez-Machado, Ana Laura; Galindo, Ruth; Cano, Amanda ; Espina, Marta; Ettcheto, Miren; Camins, Antoni; Silva, Amélia M.; Durazzo, Alessandra; Santini, Antonello; Garcia, Maria L. ; Souto, Eliana B. articleopenAccess
829-Apr-2021Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer's disease: from current to future challengesCano, Amanda ; Turowski, Patric; Ettcheto, Miren; Duskey, Jason Thomas; Tosi, Giovanni; Sánchez-López, Elena; García, Maria Luisa; Camins, Antonio; Souto, Eliana B. ; Ruiz, Agustín; Marquié, Marta; Boada, Mercè articleopenAccess
9Feb-2022Physicochemical and biopharmaceutical aspects influencing skin permeation and role of SLN and NLC for skin drug deliverySouto, Eliana ; Fangueiro, Joana F. ; Fernandes, Ana R. ; Cano, Amanda ; Sanchez-Lopez, Elena; Garcia, Maria L. ; Severino, Patrícia; Paganelli, Maria O.; Chaud, Marco V.; Silva, Amélia M. articleopenAccess
107-May-2021Psoriasis: From Pathogenesis to Pharmacological and Nano-Technological-Based TherapeuticsPetit, Robert Gironés; Cano, Amanda ; Ortiz, Alba; Espina, Marta; Prat, Josefina; Muñoz, Montserrat; Severino, Patrícia; Souto, Eliana B. ; Garcia, Maria L. ; Pujol, Montserrat; Sánchez-López, ElenaarticleopenAccess
1123-Aug-2021State of the Art on Toxicological Mechanisms of Metal and Metal Oxide Nanoparticles and Strategies to Reduce Toxicological RisksGarcía-Torra, Victor; Cano, Amanda ; Espina, Marta; Ettcheto, Miren; Camins, Antoni; Barroso, Emma; Vazquez-Carrera, Manel; García, Maria Luisa; Sánchez-López, Elena; Souto, Eliana B. articleopenAccess
122021Surface Functionalization of PLGA Nanoparticles to Increase Transport across the BBB for Alzheimer’s DiseaseDel Amo, Laura; Cano, Amanda ; Ettcheto, Miren; Souto, Eliana B. ; Espina, Marta; Camins, Antoni; García, Maria Luísa; Sánchez-López, ElenaarticleopenAccess